SCHEMBL21886504

SCHEMBL21886504

CC(=O)C1CCC(OCCOc2ccc(-c3cc(=O)c4cccc(Cl)c4o3)cc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 3/20 0.44
▸ MAOB P27338 2/20 0.42
▸ CYSLTR1 Q9Y271 4/20 0.42
▸ SIGMAR1 Q99720 4/20 0.41
▸ BCHE P06276 2/20 0.41
▸ CNR2 P34972 2/20 0.41
▸ CYP2D6 P10635 1/20 0.40
▸ ABCC1 P33527 2/20 0.40
▸ ABCG2 Q9UNQ0 2/20 0.40
▸ CYP1A1 P04798 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP1B1 Q16678 1/20 0.39
▸ HDAC3 O15379 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ CYSLTR2 Q9NS75 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21801118 0.92 CYSLTR1 (0.45) ABCB1MAOBCYSLTR1SIGMAR1BCHE
SCHEMBL21801063 0.92 CYSLTR1 (0.45) ABCB1MAOBCYSLTR1SIGMAR1BCHE
SCHEMBL21801062 0.92 CYSLTR1 (0.45) ABCB1MAOBCYSLTR1SIGMAR1BCHE
SCHEMBL21801130 0.91 MAOB (0.45) ABCB1MAOBCYSLTR1SIGMAR1BCHE
SCHEMBL21801131 0.88 CYSLTR1 (0.43) ABCB1MAOBCYSLTR1SIGMAR1BCHE
SCHEMBL21801232 0.88 MAOB (0.44) ABCB1MAOBCYSLTR1SIGMAR1BCHE
SCHEMBL21865717 0.86 ABCB1 (0.44) ABCB1MAOBCYSLTR1SIGMAR1BCHE
SCHEMBL30744108 0.86 SIGMAR1 (0.47) ABCB1MAOBCYSLTR1SIGMAR1BCHE
SCHEMBL21801191 0.85 CYSLTR1 (0.45) ABCB1MAOBCYSLTR1SIGMAR1BCHE
SCHEMBL21801081 0.85 CYSLTR1 (0.45) ABCB1MAOBCYSLTR1SIGMAR1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020052774-A1 FLAVONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2020-03-19 — — WO disclosed
Send feedback